CEO exercised or converted 247K ABT derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 25, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 27, 2026
CEOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001612571-26-000011
Filed / recordedAug 27, 2026, 9:09 PM UTCAdded to OQROOct 2, 2026, 12:26 PM UTC Data qualityVerified: identifiers matched exactly IssuerABBOTT LABORATORIES Reporting personRobert B Ford RelationshipDirector, Officer Officer titleCHAIRMAN AND CEO SecurityCommon shares without par value TableNon-derivative (Table I) Transaction dateAug 25, 2026 Acquired / disposedAcquired (A) Shares owned after705,293 Around the same time
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Abbott Laboratories's VICE PRESIDENT AND CONTROLLER sold $3K of Abbott Laboratories shares. Nobody planned it ahead of time.